Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Investor Watch

Lilly Enters into Exclusive Licensing Agreement with Rigel Pharmaceuticals Accessing Promising RIPK1 Inhibitor

Eli Lilly and Co inked a deal to gain worldwide, exclusive licensing rights to the autoimmune and inflammatory disease treatment […]

Lilly Enters into Exclusive Licensing Agreement with Rigel Pharmaceuticals Accessing Promising RIPK1 Inhibitor
2 weeks ago
Share

German Investor Christain Angermayer Lists SPAC with Biotech Focus

German investor Christian Angermayer is planning to list a blank-cheque company in New York. His Frontier Acquisition Corp., a special […]

German Investor Christain Angermayer Lists SPAC with Biotech Focus
2 weeks ago
Share

UK to Conduct World’s First Human Challenge COVID-19 Trials—Deliberate Infection of Volunteers

Back in October 2020, the United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in what’s known […]

UK to Conduct World’s First Human Challenge COVID-19 Trials—Deliberate Infection of Volunteers
2 weeks ago
Share

A New Paradigm for Patient Recruitment: Leveraging Medical Laboratory Data for Patient Recruitment

Cerba Research, a leading healthcare diagnostic company and wholly owned subsidiary of Cerba Healthcare, today announced a new partnership with […]

A New Paradigm for Patient Recruitment Leveraging Medical Laboratory Data for Patient Recruitment
2 weeks ago
Share

Fred Hutch & UW Spinoff Ensoma Secures $70m to Pioneer Next Generation In Vivo Approach to Delivery First “Off-the-shelf” Genomic Medicines

A new biotech venture called Ensoma was launched just recently, in conjunction with a sizable $70 million Series A funding […]

Fred Hutch & UW Spinoff Ensoma Secures $70m to Pioneer Next Generation In Vivo Approach to Delivery First “Off-the-shelf” Genomic Medicines
3 weeks ago
Share

Day One Biopharma Announces $130 Million Series B Financing to Advance Targeted Cancer Treatments for Children

Day One Biopharmaceuticals announced the closing of a $130 million Series B financing, led by RA Capital Management with participation […]

Day One Biopharma Announces $130 Million Series B Financing to Advance Targeted Cancer Treatments for Children
3 weeks ago
Share

Notch Therapeutics Closes $85 Million Series A for Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies

Notch Therapeutics  announced the closing of an oversubscribed $85 million Series A financing, led by an exclusively healthcare-focused investment fund. […]

Notch Therapeutics Closes $85 Million Series A for Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapies
3 weeks ago
Share

Pipeline Therapeutics Closes $80M Series C to Advance First-in-Class Small Molecules for Neuroregeneration

Pipeline Therapeutics announced the closing of an $80 million Series C financing. The oversubscribed financing was led by a healthcare-focused […]

Pipeline Therapeutics Closes $80M Series C to Advance First-in-Class Small Molecules for Neuroregeneration
3 weeks ago
Share

Anti-Aging Distributed Drug Discovery Venture Cambrian Biopharma Announces $60m Funding & First IPO of Portfolio Company

The last decades’ technological, business and social and economic breakthroughs have created unprecedented wealth worldwide. With about 50 million millionaires around […]

Anti-Aging Distributed Drug Discovery Venture Cambrian Biopharma Announces $60m Funding & First IPO of Portfolio Company
3 weeks ago
Share

Inhalable Remdesivir at Contacts or Early Onset Could Generate Large Growth for Remdesivir—Still in Early Stages Investigation

Gilead’s inhaled version of remdesivir (Veklury) could add considerable value to the COVID-19 market. Potentially, the drug could be used […]

Inhalable Remdesivir at Contacts or Early Onset Could Generate Large Growth for Remdesivir—Still inEarly Stages Investigation
3 weeks ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.